Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years
Soghra Rabizadeh
Soghra Rabizadeh

Associate Professor of Endocrinology & Metabolism

Department Internal Medicine

School of Medicine

Vali Asr Hospital

Tehran University of Medical Sciences

Related Documents
1. Iranian Patients With Diabetes and Covid-19-Associated Mucormycosis: Characteristics, Manifestations, and Mortality Risk Factors, International Journal of Diabetes in Developing Countries (2024)
All Documents
1. Association of Non-Insulin-Based Markers of Insulin Resistance With Hypertension in Type 2 Diabetes: An Age- and Gender-Matched Cross-Sectional Study, American Journal of Hypertension (2026)
2. Machine Learning Prediction of Metabolic-Associated Fatty Liver Disease in Type 2 Diabetes: Emphasizing Data Imputation and Feature Selection, PLOS ONE (2026)
3. Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma Are Correlates of Uncontrolled Hypertension in Patients With Type 2 Diabetes, Journal of Diabetes Research (2025)
4. Association Between Serum Vitamin D and Albuminuria in Type 2 Diabetes Independent of Inflammatory Markers and Renal Function, Endocrinology, Diabetes and Metabolism (2025)
5. Association Between Serum Vitamin D and Albuminuria in Type 2 Diabetes Independent of Inflammatory Markers and Renal Function, Endocrinology, Diabetes and Metabolism (2025)
6. Can Lipid Indices Aid in Predicting Diabetic Kidney Disease? Findings From a Cross-Sectional, Matched Case-Control Study, PLOS ONE (2025)
7. Empagliflozin-Based Quadruple Oral Therapy for Type 2 Diabetes: A Prospective Cohort Study, Scientific Reports (2025)
8. Estimated Glucose Disposal Rate: A Potential Determinant for Microvascular and Macrovascular Complications in Type 2 Diabetes, Endocrinology, Diabetes and Metabolism (2025)
9. Fib-4 Index Can Predict Mortality in Hospitalized Patients With Covid-19 Infection, Independent of Ct Severity Score, Archives of Iranian medicine (2025)
10. Impact of Bariatric Surgery on Liver Fibrosis Indices Among Type 2 Diabetes Patients in a National Cohort, Scientific Reports (2025)
11. Impact of Bariatric Surgery on Liver Fibrosis Indices Among Type 2 Diabetes Patients in a National Cohort, Scientific Reports (2025)
12. Investigating Serum Antithyroglobulin Antibody Trend and Response to Treatment in Patients With Differentiated Thyroid Cancer, Endocrinology Research and Practice (2025)
13. Low Ankle-Brachial Index Is Associated With Albuminuria and Diabetic Kidney Disease in Type 2 Diabetes; a Cross Sectional Study, Endocrinology, Diabetes and Metabolism (2025)
14. Neutrophil-Lymphocyte Ratio (Nlr); an Accurate Inflammatory Marker to Predict Diabetic Foot Ulcer Amputation: A Matched Case-Control Study, BMC Endocrine Disorders (2025)
15. Peri-Liver Transplant Hyperglycemia: Mechanisms, Associated Factors, Consequences, and Management – a Systematic Review, Endocrinology, Diabetes and Metabolism (2025)
16. Serum Levels of Advanced Glycation End Products Negatively Correlates With Activity of Paraoxonase1 and Lecithin-Cholesterol Acyltransferase in Diabetic Retinopathy; a Cross-Sectional Case-Control Study, Clinical Biochemistry (2025)
17. Surrogate Markers of Insulin Resistance and Coronary Artery Disease in Type 2 Diabetes: U-Shaped Tyg Association and Insights From Machine Learning Integration, Lipids in Health and Disease (2025)
18. The Effect of the Continuous Care Model on Drug Side Effects and Quality of Life in Patients With Hyperthyroidism, HAYAT (2025)
19. The Impact of Anti-Tnf-Α Therapy on Leptin and Inflammatory Markers in Rheumatoid Arthritis Patients: A Case-Control Study, BMC Rheumatology (2025)
20. The Trend of Atherogenic Indices in Patients With Type 2 Diabetes After Bariatric Surgery: A National Cohort Study, Surgery for Obesity and Related Diseases (2025)
21. The Trend of Atherogenic Indices in Patients With Type 2 Diabetes After Bariatric Surgery: A National Cohort Study, Surgery for Obesity and Related Diseases (2025)
22. What Features Predict Poorer Outcomes in Micropapillary Thyroid Carcinoma? a Retrospective Cohort Study, Endocrine Practice (2025)
23. What Features Predict Poorer Outcomes in Micropapillary Thyroid Carcinoma? a Retrospective Cohort Study, Endocrine Practice (2025)
24. Apoa1/Hdl-C Ratio As a Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes: A Matched Case-Control Study, BMC Cardiovascular Disorders (2024)
25. Atherogenic Index of Plasma (Aip): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross-Sectional Study, Endocrinology, Diabetes and Metabolism (2024)
26. Correlates of Normal and Decreased Hdl Cholesterol Levels in Type 2 Diabetes: A Cohort-Based Cross-Sectional Study, Lipids in Health and Disease (2024)
27. Effects and Safety of Resveratrol Supplementation in Older Adults: A Comprehensive Systematic Review, Phytotherapy Research (2024)
28. Glycemic Profile Variability As an Independent Predictor of Diabetic Retinopathy in Patients With Type 2 Diabetes: A Prospective Cohort Study, Frontiers in Endocrinology (2024)
29. High Prevalence of Comorbidities in Older Adult Patients With Type 2 Diabetes: A Cross-Sectional Survey, BMC Geriatrics (2024)
30. Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study, Endocrinology# Diabetes and Metabolism (2024)
31. Increased High-Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes and Its Correlates: A Cross-Sectional, Matched Case-Control Survey, European journal of medical research (2024)
32. Iranian Patients With Diabetes and Covid-19-Associated Mucormycosis: Characteristics, Manifestations, and Mortality Risk Factors, International Journal of Diabetes in Developing Countries (2024)
33. Nonalcoholic Fatty Liver Disease As a Potential Risk Factor for Cardiovascular Disease in Patients With Type 2 Diabetes: A Prospective Cohort Study, International Journal of Endocrinology (2024)
34. Relationship Between Advanced Glycation End-Products and Advanced Oxidation Protein Products in Patients With Type 2 Diabetes With and Without Albuminuria: A Cross-Sectional Survey, Health Science Reports (2024)
35. The Relationship Between Thyroid Hormones Levels and Liver Cirrhosis Prognosis Criteria and Complications: A Cross-Sectional Study, Govaresh (2024)
36. Vitamin D in Type 2 Diabetes and Its Correlation With Heat Shock Protein 70, Ferric Reducing Ability of Plasma, Advanced Oxidation Protein Products and Advanced Glycation End Products, Endocrinology, Diabetes and Metabolism (2024)
37. Waist-To-Hip Ratio As a Contributor Associated With Higher Atherosclerotic Cardiovascular Disease Risk Assessment in Patients With Diabetes: A Cross-Sectional Study, BMC Cardiovascular Disorders (2024)
38. Bilateral Inferior Petrosal Sinus Sampling: Validity, Diagnostic Accuracy in Lateralization of Pituitary Microadenoma, and Treatment in Eleven Patients With Cushing’S Syndrome – a Single-Center Retrospective Cohort Study, BMC Endocrine Disorders (2023)
39. Comparison of Insulin Resistance Indices in Predicting Albuminuria Among Patients With Type 2 Diabetes, European Journal of Medical Research (2023)
40. Correlation Between Different Levels and Patterns of Dyslipidemia and Glomerular Filtration Rate in Patients With Type 2 Diabetes: A Cross-Sectional Survey of a Regional Cohort, Journal of Clinical Laboratory Analysis (2023)
41. Decreasing Trend of Blood Lipid Profile in Type 2 Diabetes: Not a Promising Change in Hdl-C, a Serial Cross-Sectional Study, PLoS ONE (2023)
42. Eight Weeks of Vitamin C Supplementation Restores the Lost Correlation Between Serum Leptin and C-Reactive Protein (Crp) in Patients With Type 2 Diabetes; a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial, Current Pharmaceutical Design (2023)
43. Fibrosis Score 4 Index Has an Independent Relationship With Coronary Artery Diseases in Patients With Metabolic-Associated Fatty Liver Disease, Diabetology and Metabolic Syndrome (2023)
44. Glycemic Profile Variability: An Independent Risk Factor for Diabetic Neuropathy in Patients With Type 2 Diabetes, Primary Care Diabetes (2023)
45. Lipid Accumulation Product (Lap) Index for the Diagnosis of Nonalcoholic Fatty Liver Disease (Nafld): A Systematic Review and Meta-Analysis, Lipids in Health and Disease (2023)
46. Lipid Profile, Ox-Ldl, and Lcat Activity in Patients With Endometrial Carcinoma and Type 2 Diabetes: The Effect of Concurrent Disease Based on a Case–Control Study, Health Science Reports (2023)
47. Non-Alcoholic Fatty Liver Disease and Incidence of Microvascular Complications of Diabetes in Patients With Type 2 Diabetes: A Prospective Cohort Study, Frontiers in Endocrinology (2023)
48. The Lack of Association Between Different Ldl-C Levels and Oxidized Ldl in Patients With Type 2 Diabetes, Chronic Diseases and Translational Medicine (2023)
49. The Trend of Achieving Abc Goals in Patients With Type 2 Diabetes Between 2010-2014 and 2015–2019, Obesity Medicine (2023)
50. Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes, BMC Complementary Medicine and Therapies (2023)
51. Vitamin C Supplementation Lowers Advanced Glycation End Products (Ages) and Malondialdehyde (Mda) in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Food Science and Nutrition (2023)
52. Atherogenic Index of Plasma Is an Independent Predictor of Metabolic-Associated Fatty Liver Disease in Patients With Type 2 Diabetes, European Journal of Medical Research (2022)
53. Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite], Eastern Mediterranean Health Journal (2022)
54. Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes, Diabetes Therapy (2022)
55. Response to the Letter to the Editor Concerning the Manuscript, “Uncontrolled Hypertension in Patients With Type 2 Diabetes: What Are the Correlates”, Journal of Clinical Hypertension (2022)
56. The Accuracy of Triglyceride-Glucose (Tyg) Index for the Screening of Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis, Nutrition# Metabolism and Cardiovascular Diseases (2022)
57. The Association Between Advanced Glycation End Products (Ages) and Abc (Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein Cholesterol) Control Parameters Among Patients With Type 2 Diabetes Mellitus, Diabetology and Metabolic Syndrome (2022)
58. Association Between Visit-To-Visit Variability of Glycemic Indices and Lipid Profile and the Incidence of Coronary Heart Disease in Adults With Type 2 Diabetes, Journal of Diabetes and Metabolic Disorders (2021)
59. Correlates of Recurrence-Free Survival in Papillary Thyroid Carcinoma: A Cohort Study in an Iranian Population; [Papiller Tiroid Karsinomunda Nukssuz Sagkalim Ile Iliskili Faktorler: Iran Populasyonunda Bir Kohort Calismasi], Turkish Journal of Endocrinology and Metabolism (2021)
60. Improvement in Redox Homeostasis After Cytoreductive Surgery in Colorectal Adenocarcinoma, Oxidative Medicine and Cellular Longevity (2021)
61. Ldl/Apo B Ratio Predict Coronary Heart Disease in Type 2 Diabetes Independent of Ascvd Risk Score: A Case-Cohort Study, Nutrition# Metabolism and Cardiovascular Diseases (2021)
62. The Effect of Vitamin D Deficiency State on Oxidized Low-Density Lipoprotein Alteration in Patients With Type 2 Diabetes, Functional Foods in Health and Disease (2021)
63. Uncontrolled Hypertension in Patients With Type 2 Diabetes: What Are the Correlates?, Journal of Clinical Hypertension (2021)
64. Waist-To-Height Ratio Is a More Accurate Tool for Predicting Hypertension Than Waist-To-Hip Circumference and Bmi in Patients With Type 2 Diabetes: A Prospective Study, Frontiers in Public Health (2021)
65. Advanced Glycation End-Products and Advanced Oxidation Protein Products Levels Are Correlates of Duration of Type 2 Diabetes, Life Sciences (2020)
66. Barriers to Initiation of Insulin Therapy in Poorly Controlled Type 2 Diabetes Based on Self-Determination Theory; [Obstacles Face a La Mise En Place De L’Insulinotherapie Dans Le Diabete De Type 2 Mal Controle Selon La Theorie De L’Autodetermination], Eastern Mediterranean Health Journal (2020)
67. Dpp4 Inhibitors in the Management of Hospitalized Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, Advances in Therapy (2020)
68. Inadequate Achievement of Abc Goals (Hba1c, Blood Pressure, Ldl-C) Among Patients With Type 2 Diabetes in an Iranian Population, 2012–2017, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2020)
69. Lecithin-Cholesterol Acyltransferase (Lcat) Activity Is Lower in Patients With Type 2 Diabetes in the Presence of Metabolic Syndrome, Bioactive Compounds in Health and Disease (2020)
70. Lp(A) and Apo-Lipoproteins As Predictors for Micro- and Macrovascular Complications of Diabetes: A Case-Cohort Study, Nutrition# Metabolism and Cardiovascular Diseases (2020)
71. Nitric Oxide and Tnf-Α Are Correlates of Diabetic Retinopathy Independent of Hs-Crp and Hba1c, Endocrine (2020)
72. Serum Hsp70 Level in Patients With Endometrial Cancer With and Without Diabetes, Gynecological Endocrinology (2020)
73. Severe Diabetic Ketoacidosis and Coronavirus Disease 2019 (Covid-19) Infection in a Teenage Patient With Newly Diagnosed Diabetes, Journal of Pediatric Endocrinology and Metabolism (2020)
74. Association of Extracellular Heat Shock Protein 70 and Insulin Resistance in Type 2 Diabetes; Independent of Obesity and C-Reactive Protein, Cell Stress and Chaperones (2019)
75. Cardiovascular and Renal Benefits of Sglt2 Inhibitors: A Narrative Review, International Journal of Endocrinology and Metabolism (2019)
76. Comparison of Primary Versus Secondary Prevention of Cardiovascular Disease in Patients With Type2 Diabetes: Focus on Achievement of Abc Goals, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)
77. Definition of an Oxidative Stress Status by Combined Assessment of Malondialdehyde and Oxidized-Ldl: A Study in Patients With Type2 Diabetes and Control, Meta Gene (2019)
78. Ectopic Cushing’S Syndrome Due to Corticotropin Releasing Hormone, Pituitary (2019)
79. Gender Difference in Plasminogen Activator Inhibitor-1 Activity in Patients With Type 2 Diabetes With and Without Albuminuria, a Matched Case-Control Study, Functional Foods in Health and Disease (2019)
80. Inflammatory, Oxidative Stress and Anti-Oxidative Markers in Patients With Endometrial Carcinoma and Diabetes, Cytokine (2019)
81. Leptin, Hs-Crp and Homa-Ir in Patients With Type 2 Diabetes: The Role of Different Levels of Vitamin D Deficiency, Functional Foods in Health and Disease (2019)
82. Loss of Inverse Association Between Framingham Risk Score and Estimated Glomerular Filtration Rate in Moderate to Severe Diabetic Kidney Disease, Archives of Iranian Medicine (2019)
83. Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes With Nephropathy, American Journal of the Medical Sciences (2018)
84. Pulse Pressure and Diabetes Treatments: Blood Pressure and Pulse Pressure Difference Among Glucose Lowering Modality Groups in Type 2 Diabetes, Medicine (United States) (2018)
85. All-Cause and Cardiovascular Mortality Following Treatment With Metformin or Glyburide in Patients With Type 2 Diabetes Mellitus, Archives of Iranian Medicine (2017)
86. Changing Correlations Among Adma, No and Hs-Crp in Normoalbuminuric and Microalbuminuric Patients With Type 2 Diabetes, Meta Gene (2016)